Physician profile
Thomas J Meyer
NPI 1700812641
$615,136.48
in general payments reported to CMS, 2019-2025
40 companies · $114K in 2025
The $114K reported for 2025 was more than what 99% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,876 · 2020: $334 · 2021: $98K · 2022: $191K · 2023: $126K · 2024: $82K · 2025: $114K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $246K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $44K · Food and Beverage: $14K · Travel and Lodging: $12K · Consulting Fee: $6,300 · Gift: $21.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $246,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $43,750.00 |
| Food and Beverage | $14,257.30 |
| Travel and Lodging | $12,142.90 |
| Consulting Fee | $6,300.00 |
| Gift | $21.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $598,183.76 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Galvanize Therapeutics, INC | $8,874.69 | 2023-2025 | Aliya System |
| Astrazeneca Pharmaceuticals Lp | $1,671.69 | 2019-2025 | Fasenra, Breztri, Tezspire |
| Glaxosmithkline, LLC. | $1,276.79 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Ethicon INC. | $816.30 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $577.31 | 2019-2023 | Stiolto Respimat, Spiriva Respimat, Combivent Respimat |
| Genzyme Corporation | $519.36 | 2019-2025 | |
| Mylan Specialty L.P. | $467.90 | 2019-2024 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $311.44 | 2022-2025 | Dupixent |
| Insmed, INC. | $274.11 | 2019-2025 | Arikayce, Brinsupri |
| Philips North America LLC | $219.57 | 2019-2025 | Vest Therapy Und |
| Ani Pharmaceuticals, INC. | $210.09 | 2022-2025 | Purified Cortrophin Gel |
| Genentech USA, INC. | $173.72 | 2019-2025 | Xolair |
| Celgene Corporation | $155.17 | 2019 | |
| Mallinckrodt Hospital Products INC. | $133.16 | 2022-2023 | Acthar |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $113.01 | 2022-2024 | Aralast |
| Abbvie INC. | $109.13 | 2022-2025 | |
| Verona Pharma, INC. | $104.51 | 2025 | Ohtuvayre |
| Sanofi-Aventis U.S. LLC | $96.50 | 2022 | |
| Novartis Pharmaceuticals Corporation | $89.21 | 2019-2025 | |
| Inogen, INC. | $84.26 | 2023-2025 | Inogen One G3 Oxygen Concentrator |
| United Therapeutics Corporation | $77.64 | 2022-2024 | Tyvaso |
| Viatris Specialty LLC | $72.73 | 2025 | Yupelri |
| Baxter Healthcare | $68.01 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Pulmonx Corporation | $62.76 | 2019-2025 | Zephyr Endobronchial Valve, Zephyr Delivery Catheter, Chartis Catheter |
| E.R. Squibb & Sons, L.L.C. | $51.44 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $51.12 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $43.19 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $36.42 | 2022-2024 | Winrevair |
| Amgen INC. | $26.67 | 2024 | Tezspire |
| Vifor Pharma, INC. | $22.02 | 2024 | Zemaira |
| Grifols USA, LLC | $21.49 | 2020 | |
| Kaleo, INC. | $20.49 | 2019 | |
| Allergan, INC. | $19.80 | 2019 | |
| Auris Health, INC. | $19.57 | 2019 | |
| Pfizer INC. | $19.56 | 2024 | |
| Boston Scientific Corporation | $18.78 | 2023 | |
| Erbe USA INC | $15.00 | 2023 | |
| Circassia INC. | $14.17 | 2019 | |
| Siemens Medical Solutions USA, INC. | $13.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Meyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.